We develop therapeutic solutions for respiratory virus diseases such as corona, influenza and RSV infections, to support global efforts to prepare for future pathogen threats.
We enable large-scale AAT manufacturing through cutting-edge recombinant technology.We utilize state-of-the-art inhaler technology and other technologies for safe, effective and convenient AAT drug administration.